News
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.
Health Canada says it is working with manufacturers to make diabetes drugs, including Ozempic, more available during a worldwide shortage fuelled by high demand that’s expected to last into the ...
A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, manufacturer Novo Nordisk and Health Canada said on Friday. We are experiencing a temporary ...
Diabetes drug Ozempic is shown at a pharmacy in Toronto on Wednesday, April 19, 2023. Health Canada says it is working with manufacturers to make diabetes drugs, including Ozempic, more ...
The lower-dose Ozempic injection pens of 0.25 mg and 0.5 mg remain available and “may be an option for some patients” as an alterative, Health Canada’s web page said.
Ozempic mimics a hormone, GLP-1, which tells the brain that food is coming in and to stop eating. The rest of the body knows what to do once you give the signal that food is coming, Lin said.
Health Canada has approved Wegovy as a weight loss medication. These drugs and other similar ones including Mounjaro, Victoza and Trulicity, belong to the glucagon-like peptide 1 (GLP-1) agonists ...
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback